1. PARP-1 promotes autophagy via the AMPK/mTOR pathway in CNE-2 human nasopharyngeal carcinoma cells following ionizing radiation, while inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells
   ZE-TAN CHEN et al, 2015 CrossRef
2. Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1α/IGFBP1 pathway
   Jiaojiao Gong et al, 2017 CrossRef
3. The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis
   Angela Kwok-Fung Lo et al, 2017, Int. J. Cancer CrossRef
4. Expression and roles of fatty acid synthase in hepatocellular carcinoma.
   Qiwei Hao et al, 2014, Oncol. Rep. CrossRef
5. Inactivation of HMGCL promotes proliferation and metastasis of nasopharyngeal carcinoma by suppressing oxidative stress
   Wenqi Luo et al, 2017, Sci Rep CrossRef
6. Rediscovery of NF-κB signaling in nasopharyngeal caicrnoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
   Mei Yi et al, 2018, J Cell Physiol CrossRef
7. Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas
   Pier P. Piccaluga et al, 2018, Front. Microbiol. CrossRef
8. Flavonoid–alkylphospholipid conjugates elicit dual inhibition of cancer cell growth and lipid accumulation
   Zhengwei Zhou et al, 2019, Chem. Commun. CrossRef
9. Viral hijacking of cellular metabolism
   Shivani K. Thaker et al, 2019, BMC Biol CrossRef
10. The labyrinth of interactions of Epstein-Barr virus-encoded small RNAs
    Waqar Ahmed et al, 2014, Rev. Med. Virol. CrossRef
11. A metabolic discrimination model for nasopharyngeal carcinoma and its potential role in the therapeutic evaluation of radiotherapy
    Lunzhao Yi et al, 2014, Metabolomics CrossRef
12. Wnt directs the endosomal flux of LDL-derived cholesterol and lipid droplet homeostasis.
    Cameron C Scott et al, 2015, EMBO Rep CrossRef
13. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma
    Zhi Li et al, 2015, Oncotarget CrossRef
14. Epigenetic downregulation of the ISG15-conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma
    Xiaoying Zhou et al, 2015, Oncotarget CrossRef
15. Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein–Barr Virus Infected Cells
    Gayathri Krishna et al, 2020, Viruses CrossRef
16. Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis
    Timmy Richardo et al, 2020, Cancers CrossRef
17. Downregulation of adipose triglyceride lipase by EB viral‐encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma
    Shixing Zheng et al, 2020, Mol Oncol CrossRef
18. Virus Infections and Host Metabolism—Can We Manage the Interactions?
    Deepak Sumbria et al, 2021, Front. Immunol. CrossRef
19. From infection to cancer: how DNA tumour viruses alter host cell central carbon and lipid metabolism
    Kamini L. Magon et al, 2021, Open Biol. CrossRef
20. null
    Witchuda Sukjoi et al, 2021 CrossRef
21. Epstein-Barr virus noncoding small RNA (EBER1) induces cell proliferation by up-regulating cellular mitochondrial activity and calcium influx
    Waqar Ahmed et al, 2021, Virus Research CrossRef
22. Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma
    Huimei Huang et al, 2021, Front. Immunol. CrossRef
23. Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
    Katherine E. Havranek et al, 2021, Viruses CrossRef
24. Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance
    Mai K. L. Nguyen et al, 2022, IJMS CrossRef
25. Integration Profiling Between Plasma Lipidomics, Epstein–Barr Virus and Clinical Phenomes in Nasopharyngeal Carcinoma Patients
    Yi Huang et al, 2022, Front. Microbiol. CrossRef
26. Interplay between cellular metabolism and DNA viruses
    Milad Zandi et al, 2022, Journal of Medical Virology CrossRef
27. Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview
    Xiangwan Miao et al, 2022, Front. Oncol. CrossRef
28. Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers—A Focus on EBV and KSHV Life Cycles and Carcinogenesis
    Sherif T. S. Hassan et al, 2022, IJMS CrossRef
29. Oncogenic viruses and host lipid metabolism: a new perspective
    Zhiyuan Gong et al, 2023 CrossRef
30. Targeting dysregulated lipid metabolism in the tumor microenvironment
    Do-Hee Kim et al, 2023, Arch. Pharm. Res. CrossRef
31. Metabolic Enzymes in Viral Infection and Host Innate Immunity
    Chao Qin et al, 2023, Viruses CrossRef
32. Virus‐induced host cell metabolic alteration
    Syed Shahariar Bappy et al, 2024, Reviews in Medical Virology CrossRef
33. Metabolic reprogramming in the pathogenesis and progression of nasopharyngeal carcinoma: molecular mechanisms and therapeutic implications
    Hongli Wang, 2024, Am J Cancer Res CrossRef
34. Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities
    Saheem Ahmad et al, 2024, International Journal of Biological Macromolecules CrossRef
35. Research progress on EBV infection and metabolic remodeling
    Ya CAO et al, 2024, Sci. Sin.-Vitae CrossRef
36. Understanding Metabolic Pathway Rewiring by Oncogenic Gamma Herpesvirus
    Un Yung Choi et al, 2024, J. Microbiol. Biotechnol. CrossRef